Over the last 2 years, the United States and the rest of the world have seen the immense value of research and development of new tools, technologies, drugs, and vaccines to combat infectious disease threats. This session will take stock of what worked well, where we struggled most, and how we can modernize the U.S. government’s investments, structures, and partnerships in R&D to transform our capabilities and prevent future pandemics.
Anita Cicero, JD, Deputy Director, Johns Hopkins Center for Health Security
Senator Tammy Baldwin, D-WI (Invited)
Congresswoman Anna Eshoo, D-CA (Invited)
Eric Lander, MD, Director, White House Office of Science and Technology Policy
Dawn O’Connell, JD, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
Gigi Gronvall, PhD, Senior Scholar, The Johns Hopkins Center for Health Security